HomeBUSINESS
BUSINESS

JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
(Oct.17.2018)

While a major atopic dermatitis drug by Sanofi made a Japan debut this spring, a number of JAK inhibitors are jostling in a development race to follow suit, with at least five compounds being investigated in the country. As most of them are in late-stage trials, the first submission could come in the near future ...
(LOG IN FOR FULL STORY)